Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 22669842)

1.

Role of genetic modifiers in an orthologous rat model of ARPKD.

O'Meara CC, Hoffman M, Sweeney WE Jr, Tsaih SW, Xiao B, Jacob HJ, Avner ED, Moreno C.

Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5.

2.

Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.

Yoshihara D, Kugita M, Sasaki M, Horie S, Nakanishi K, Abe T, Aukema HM, Yamaguchi T, Nagao S.

PLoS One. 2013 Dec 6;8(12):e81480. doi: 10.1371/journal.pone.0081480. eCollection 2013.

3.

Disease stage characterization of hepatorenal fibrocystic pathology in the PCK rat model of ARPKD.

Mason SB, Liang Y, Sinders RM, Miller CA, Eggleston-Gulyas T, Crisler-Roberts R, Harris PC, Gattone VH 2nd.

Anat Rec (Hoboken). 2010 Aug;293(8):1279-88. doi: 10.1002/ar.21166.

4.

Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease.

Masyuk TV, Huang BQ, Masyuk AI, Ritman EL, Torres VE, Wang X, Harris PC, Larusso NF.

Am J Pathol. 2004 Nov;165(5):1719-30.

5.

Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.

Masyuk TV, Radtke BN, Stroope AJ, Banales JM, Masyuk AI, Gradilone SA, Gajdos GB, Chandok N, Bakeberg JL, Ward CJ, Ritman EL, Kiyokawa H, LaRusso NF.

Gastroenterology. 2012 Mar;142(3):622-633.e4. doi: 10.1053/j.gastro.2011.11.036. Epub 2011 Dec 7.

6.

The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.

Goto M, Hoxha N, Osman R, Dell KM.

Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.

PMID:
20798958
7.

Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys.

Hu B, He X, Li A, Qiu Q, Li C, Liang D, Zhao P, Ma J, Coffey RJ, Zhan Q, Wu G.

Exp Cell Res. 2011 Jan 15;317(2):173-87. doi: 10.1016/j.yexcr.2010.09.012. Epub 2010 Sep 25.

PMID:
20875407
8.

Molecular genetics of autosomal recessive polycystic kidney disease.

Harris PC, Rossetti S.

Mol Genet Metab. 2004 Feb;81(2):75-85. Review.

PMID:
14741187
9.

Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD.

Park F, Sweeney WE Jr, Jia G, Akbulut T, Mueller B, Falck JR, Birudaraju S, Roman RJ, Avner ED.

Am J Physiol Renal Physiol. 2009 Mar;296(3):F575-82. doi: 10.1152/ajprenal.90705.2008. Epub 2009 Jan 7. Erratum in: Am J Physiol Renal Physiol. 2009 Oct;297(4):F1135.

10.

Algorithm for efficient PKHD1 mutation screening in autosomal recessive polycystic kidney disease (ARPKD).

Bergmann C, Küpper F, Dornia C, Schneider F, Senderek J, Zerres K.

Hum Mutat. 2005 Mar;25(3):225-31. Review.

PMID:
15706593
11.

Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat.

Masyuk TV, Huang BQ, Ward CJ, Masyuk AI, Yuan D, Splinter PL, Punyashthiti R, Ritman EL, Torres VE, Harris PC, LaRusso NF.

Gastroenterology. 2003 Nov;125(5):1303-10.

PMID:
14598246
12.

Kidney cysts, pancreatic cysts, and biliary disease in a mouse model of autosomal recessive polycystic kidney disease.

Williams SS, Cobo-Stark P, James LR, Somlo S, Igarashi P.

Pediatr Nephrol. 2008 May;23(5):733-41. doi: 10.1007/s00467-007-0735-4. Epub 2008 Feb 20.

PMID:
18286309
13.

Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).

Sweeney WE Jr, Avner ED.

Cell Tissue Res. 2006 Dec;326(3):671-85. Epub 2006 Jun 10. Review.

PMID:
16767405
14.

Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease.

Muff MA, Masyuk TV, Stroope AJ, Huang BQ, Splinter PL, Lee SO, Larusso NF.

Lab Invest. 2006 Sep;86(9):940-50. Epub 2006 Jun 19.

15.

A novel gene encoding a TIG multiple domain protein is a positional candidate for autosomal recessive polycystic kidney disease.

Xiong H, Chen Y, Yi Y, Tsuchiya K, Moeckel G, Cheung J, Liang D, Tham K, Xu X, Chen XZ, Pei Y, Zhao ZJ, Wu G.

Genomics. 2002 Jul;80(1):96-104.

PMID:
12079288
16.

Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene.

Gattone VH 2nd, MacNaughton KA, Kraybill AL.

Anat Rec. 1996 Jul;245(3):488-99.

PMID:
8800407
17.
18.

Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD).

Bergmann C, Senderek J, Windelen E, Küpper F, Middeldorf I, Schneider F, Dornia C, Rudnik-Schöneborn S, Konrad M, Schmitt CP, Seeman T, Neuhaus TJ, Vester U, Kirfel J, Büttner R, Zerres K; APN (Arbeitsgemeinschaft für Pädiatrische Nephrologie).

Kidney Int. 2005 Mar;67(3):829-48.

PMID:
15698423
19.

Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease.

Togawa H, Nakanishi K, Mukaiyama H, Hama T, Shima Y, Sako M, Miyajima M, Nozu K, Nishii K, Nagao S, Takahashi H, Iijima K, Yoshikawa N.

Am J Physiol Renal Physiol. 2011 Feb;300(2):F511-20. doi: 10.1152/ajprenal.00038.2010. Epub 2010 Nov 17.

20.

Molecular and cellular pathogenesis of autosomal recessive polycystic kidney disease.

Menezes LF, Onuchic LF.

Braz J Med Biol Res. 2006 Dec;39(12):1537-48. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk